Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
about
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancerAbnormal muscle afferent function in a model of Taxol chemotherapy-induced painful neuropathyPhase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the ratMuscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathyThe challenge of preserving cardiorespiratory fitness in physically inactive patients with colon or breast cancer during adjuvant chemotherapy: a randomised feasibility study
P2860
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@ast
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@en
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@nl
type
label
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@ast
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@en
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@nl
prefLabel
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@ast
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@en
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@nl
P2093
P2860
P356
P1476
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.278
P407
P577
1998-05-01T00:00:00Z
P5875
P6179
1012536622